3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Interventions
pembrolizumab
18
Specimen Handling
16
Magnetic Resonance Spectroscopy
11
Biopsy
11
Paclitaxel
8
Carboplatin
8
trastuzumab deruxtecan
6
Pemetrexed
6
Nivolumab
6
Irinotecan
6
Fulvestrant
6
Bevacizumab
6
Radiosurgery
5
Leucovorin
5
Gemcitabine
5
Fluorouracil
5
Cetuximab
5
palbociclib
4
Oxaliplatin
4
Letrozole
4
Cisplatin
4
olaparib
3
durvalumab
3
Taxes
3
Ipilimumab
3
Docetaxel
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
ribociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Transplantation Conditioning
×
30 days
×
Clear all
NCT07627711
2026-06-04
DUAL-NK-PDAC
Beijing Biotech
Phase 1/2
Recruiting
42 enrolled